In Vitro Antifungal Activity of Hexahydropyrimidine Derivatives against the Causative Agents of Dermatomycosis

Figure 2

Electron micrographs of M. canis ATCC 32903 exposed or not to the reference drugs and hexahydropyrimidine derivative of interest. (a) M. canis ATCC 32903 not subjected to pharmacological treatment; (b) fungus M. canis ATCC 32903 subjected to treatment with terbinafine; (c) M. canis ATCC 32903 subjected to treatment with ketoconazole; (d) M. canis ATCC 32903 subjected to treatment with HHP3; (e) M. canis ATCC 32903 subjected to treatment with HHP4. Arrows indicate the appearance of wrinkled (I) and crushed (II) hyphae and the presence of macroconidium (III).

(a)

(b)

(c)

(d)

(e)